ANTIFUNGAL ACTIVITY OF A SECONDARY METABOLITE OF AZADIRACHTA INDICA AND ITS DERIVATIVES – AN IN SILICO STUDY

Authors

  • Simhadri Vsdna Nagesh Department of Pharmacology, Bharath University, Tagore Medical College and Hospital, Chennai, Tamil Nadu, India.
  • Muniappan M Department of Pharmacology, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India
  • Kannan I Department of Microbiology, Tagore Medical College and Hospital, Chennai, Tamil Nadu, India.
  • Viswanathan S Department of Pharmacology, Meenakshi Medical, College and Hospital, Chennai, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i1.22171

Keywords:

Azadirachtin, 1, Nil, Dermatophytes, Open babel, SWISS ADME, iGEMDOCK, Autodock vina

Abstract

 

 Objective: This study was aimed to inhibit the 1, 3 β-glucan synthase with azadirachtin or with the derivatives by docking method.

Methods: The homology model of the protein 1, 3 β glucan synthase was prepared with easy modellar†using query sequence and template and it was validated with procheck of Ramachandran plot. The ligand was selected from the PubChem database, and the .sdf file was downloaded which was converted to another file format with open babel. The .pdb files of protein and ligand were uploaded for rough docking with iGEMDOCK, and finally, the accurate docking was made with autodock vina. The docked poses were visualized with PYMOL then saved. The derivatives of the ligand were generated with SWISS ADME, free online software, and selected the derivative for docking.

Results: The results obtained from iGEMDOCK and Autodock Vina were tabulated. It was found out that the Azadirachtin and the derivatives are effective in binding 1, 3 β Glucan synthase and thereby inhibiting the formation and integrity of fungal cell wall.

Conclusion: In this study, the secondary metabolite Azadirachtin and the derivatives are showing inhibitory action against the model protein 1, 3 β glucan synthase and it was suggested that the external application of the ligand and its derivatives can be used because of their poor oral bioavailability.

Downloads

Download data is not yet available.

References

de Jussieu A. Mémoire sur le groupe des Méliacéas. Mem Mus Hist Nat Paris 1830;19:153-304.

Rao AD, Devi KN, Thyagaraju K. Mechanism of antioxidant activity in neem. J Enzyme Inhib 1998;14:85-6.

Tidjani MA, Dupont C, Wepierre J. Azadirachta indica stem bark extract anti-inflammatory activity. Planta Med Phytother 1989;23:259-66.

Khan M, Wassilew SW, Schmutterer H, Ascher KR. Natural Pesticides From the Neem Tree and Other Tropical Plants. Eschborn, Germany: Proceedings of 3rd International Neem Conference; 1987. p. 460-6.

Maragathavalli S, Brindha S, Kaviyarasi NS, Annadurai B, Gangwar SK. Antimicrobial activity in leaf extract of Neem (Azadirachta indica Linn). Int J Sci Nat 2012;3:110-3.

Almas K. The antimicrobial effects of extracts of Azadirachta indica (Neem) and Salvadora persica (Arak) chewing sticks. Indian J Dent Res 1999;10:23-6.

Subapriya R, Nagini S. Medicinal properties of neem leaves: A review. Curr Med Chem Anticancer Agents 2005;5:149-6.

Krishnan Y, Wong NK. Cytotoxicity and antimicrobial properties of neem (Azadirachta indica) leaf extracts. Int J Pharm Pharm Sci 2015;7:179-82.

Jaafar NS, Hamad MN, Abbas IS, Jaafar IS. Qualitative phytochemical comparison between flavonoids and phenolic acids contents of leaves and fruits of Melia azedarach (Family: Meliaceae) cultivated in Iraq by HPLC and HPTLC. Int J Pharm Pharm Sci 2016;8:242-50.

Locke JC. Fungi. In: Schmutterer H, editor. The Neem Tree. Weinheim, Germany: VHC; 1995. p. 118-26.

Klis FM, Boorsma A, de Groot PW. Cell wall construction in Saccharomyces cerevisiae. Yeast 2006;23:185-202.

Latgé JP. The cell wall: A carbohydrate armour for the fungal cell. Mol Microbiol 2007;66:279-90.

Lesage G, Bussey H. Cell wall assembly in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 2006;70:317-43.

Douglas CM, Foor F, Marriman JA, Morin N, Nielsen JB, Dahl AM, et al. The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-b-D-glucan synthase. Proc Natl Acad Sci USA 1994;91:12907-11.

Thompson JR, Douglas CM, Li W, Jue CK, Pramanik B, Yuan X, et al. A glucan synthase FKS1 homolog in cryptococcus neoformans is single copy and encodes an essential function. J Bacteriol 1999;181:444-53.

Frost DJ, Brandt K, Capobianco J, Goldman R. Characterization of (1,3)-beta-glucan synthase in Candida albicans: Microsomal assay from the yeast or mycelial morphological forms and a permeabilized whole-cell assay. Microbiology 1994;140:2239-46.

Chen SC, Slavin MA, Sorrell TC. Echinocandin antifungal drugs in fungal infections. Drugs 2011;71:11-41.

Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3-26.

Lipinski CA. Lead-and drug-like compounds: The rule-of-five revolution. Drug Discov Today Technol 2004;1:337-41.

Leo A, Hansch C, Elkins D. Partition coefficients and their uses. Chem Rev 1971;71:525-616.

Richardson JS. The anatomy and taxonomy of protein structure. Adv Protein Chem 1981;34:167-339.

Ramachandran GN, Ramakrishnan C, Sasisekharan V. Stereochemistry of polypeptide chain configurations. J Mol Biol 1963;7:95-9.

Baron S, Dixon DM, Walsh TJ. Antifungal agents. Medical Microbiology. 4th ed. Ch. 76. Galveston: University of Texas Medical Branch; 1996.

Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455-61.

Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717.

Daina A, Michielin O, Zoete V. iLOGP: A simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach. J Chem Inf Model 2014;54:3284-301.

Daina A, Zoete V. A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 2016;11:1117-21.

Jeyam M, Arangaraj M, Ravikumar P, Shalini G. Computational analysis of phytocompounds with 1, 3-β-D-Glucan synthase for antidermatophytic activity. J Appl Pharm Sci 2014;4:64-9.

Urbina JM, Cortés JC, Palma A, López SN, Zacchino SA, Enriz RD, et al. Inhibitors of the fungal cell wall. Synthesis of 4-Aryl-4-N-arylamine-1-butenes and related compounds with inhibitory activities on β (1-3) glucan and chitin synthases. Bioorg Med Chem 2000;8:691-8.

Onishi J, Meinz M, Thompson J, Curotto J, Dreikorn S, Rosenbach M, et al. Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother 2000;44:368-77.

Published

01-01-2018

How to Cite

Nagesh, S. V., M. M, K. I, and V. S. “ANTIFUNGAL ACTIVITY OF A SECONDARY METABOLITE OF AZADIRACHTA INDICA AND ITS DERIVATIVES – AN IN SILICO STUDY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 1, Jan. 2018, pp. 175-84, doi:10.22159/ajpcr.2018.v11i1.22171.

Issue

Section

Original Article(s)